Cardiac Remodeling Following Transcatheter Tricuspid Valve Annuloplasty for Tricuspid Regurgitation
JACC: Cardiovascular Interventions · 2025
DOI: 10.1016/j.jcin.2025.10.010 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift JACC: Cardiovascular Interventions, 2025. Verfasst von Caroline Hasse und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, University Hospital Cologne, Germany. Electronic address: caroline.hasse@uk-koeln.de. Hauptthemen laut MEDLINE: Tricuspid Valve Insufficiency, Ventricular Remodeling, Cardiac Catheterization, Tricuspid Valve. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: Transcatheter tricuspid valve annuloplasty (TTVA) with the Cardioband has proved to be safe and effective in acutely reducing tricuspid regurgitation (TR). However, long-term outcomes, especially regarding right heart remodeling (RHR), are scarce. OBJECTIVES: The aim of this study was to assess long-term efficacy as well as RHR following TTVA. METHODS: This retrospective, multicenter study included consecutive patients undergoing TTVA for severe TR at 2 German high-volume centers from 2019 to 2023. Right atrial and right ventricular (RV) parameters and NYHA functional class were assessed at baseline and follow-up. RESULTS: A total of 156 patients were included, and the median time to follow-up was 435 days (Q1-Q3: 156-704 days). TR reduction to ≤2+ was observed in 71% and NYHA functional class improved to ≤II in 68% (P < 0.001 for both). Compared with baseline, right atrial area (36.0 ± 10.1 cm2 vs 30.4 ± 10.7 cm2), RV length (67.5 ± 9.4 mm vs 63.7 ± 9.1 mm), RV midventricular dimension (42.6 ± 8.6 mm vs 35.6 ± 7.8 mm), and RV basal dimension (47.8 ± 6.8 mm vs 42.6 ± 7.5 mm)were significantly reduced at follow-up (P < 0.001 for all). Notably, torrential to severe TR reduction still yielded remodeling (RV basal diameter 50 ± 8.1 mm vs 44 ± 8 mm; P = 0.007). RHR was associated with a decrease in vena contracta width (OR: 1.14; 95% CI: 1.03-1.30; P = 0.015). CONCLUSIONS: TTVA is associated with a significant and sustained reduction of TR for more than 1 year. Additionally, patients demonstrated distinct positive cardiac remodeling and functional improvement.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, University Hospital Cologne, Germany. Electronic address: caroline.hasse@uk-koeln.de.
- Department of Cardiology, University Hospital Cologne, Germany.
- Clinic for General and Interventional Cardiology/Angiology, Heart and Diabetes Center NRW, Ruhr University Bochum, University of Bielefeld, Bad Oeynhausen, Germany.
Zitieren
APA
Hasse, C., von Stein, P., Althoff, J., Curio, J., Schäfer, M., Kirchner, J., Rudolph, F., Gietzen, T., von Stein, J., Wrobel, J., Iliadis, C., Gerçek, M., Friedrichs, K. P., Rudolph, V., Pfister, R., Baldus, S., & Koerber, M. I. (2025). Cardiac Remodeling Following Transcatheter Tricuspid Valve Annuloplasty for Tricuspid Regurgitation. JACC: Cardiovascular Interventions. https://doi.org/10.1016/j.jcin.2025.10.010
Vancouver
Hasse C, von Stein P, Althoff J, Curio J, Schäfer M, Kirchner J, et al. Cardiac Remodeling Following Transcatheter Tricuspid Valve Annuloplasty for Tricuspid Regurgitation. JACC: Cardiovascular Interventions. 2025. doi:10.1016/j.jcin.2025.10.010
BibTeX
@article{Hasse2025,
author = {Hasse, Caroline and von Stein, Philipp and Althoff, Jan and Curio, Jonathan and Schäfer, Matthieu and Kirchner, Johannes and Rudolph, Felix and Gietzen, Thorsten and von Stein, Jennifer and Wrobel, Jan and Iliadis, Christos and Gerçek, Muhammed and Friedrichs, Kai P and Rudolph, Volker and Pfister, Roman and Baldus, Stephan and Koerber, Maria I},
title = {Cardiac Remodeling Following Transcatheter Tricuspid Valve Annuloplasty for Tricuspid Regurgitation},
journal = {JACC: Cardiovascular Interventions},
year = {2025},
doi = {10.1016/j.jcin.2025.10.010}
}
EUVIMED